BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

Diameter Capital Partners LP's Holding History (CIK: 0001727012)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 17,257,000 Value ($000) $14,650 Avg Close — Range —
Q3 2023
Shares 52,257,000 Value ($000) $39,745 Avg Close — Range —
Q2 2023
Shares 71,757,000 Value ($000) $44,222 Avg Close — Range —
Q1 2023
Shares 43,287,000 Value ($000) $27,670 Avg Close — Range —
Q4 2022
Shares 43,287,000 Value ($000) $16,787 Avg Close — Range —
Q3 2022
Shares 43,287,000 Value ($000) $19,142 Avg Close — Range —
Q2 2022
Shares 69,500,000 Value ($000) $27,974 Avg Close — Range —
Q1 2022
Shares 65,894,000 Value ($000) $31,800 Avg Close — Range —